{"id":"W2074635429","doi":"10.1097/cad.0b013e32831fb500","title":"Sorafenib tosylate in advanced kidney cancer: past, present and future","year":2009,"lang":"en","type":"review","venue":"Anti-Cancer Drugs","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Sorafenib; Medicine; Sunitinib; Kidney cancer; Oncology; Internal medicine; Cancer; Pharmacology; Clinical trial; Population; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001525448,0.0008849124,0.00306222,0.0003497798,0.00007286075,0.00004269832,0.0002264944,0.0004594725,0.0002493788],"category_scores_gemma":[0.000005519193,0.0006568344,0.0004876257,0.0005879885,0.0000874465,0.0001307912,0.0001083499,0.0008015652,0.00003999771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007660861,"about_ca_system_score_gemma":0.001034293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005404354,"about_ca_topic_score_gemma":0.00003709768,"domain_scores_codex":[0.9967428,0.0001340046,0.0008335685,0.001074118,0.000497235,0.0007182641],"domain_scores_gemma":[0.9981697,0.00005641268,0.0004309417,0.0007416183,0.00009035208,0.0005109735],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006218745,0.0001473119,0.0003049749,0.01166997,0.0002982135,0.0002312185,0.0002289151,0.000002239721,0.000008216634,0.000007158535,0.0120295,0.9750101],"study_design_scores_gemma":[0.002062903,0.0001631399,0.0009472181,0.01835271,0.001470891,0.0000580876,0.00003883758,0.000004461132,0.0000790796,0.00001108862,0.9762565,0.0005550299],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00142425,0.9881216,4.888583e-7,0.005221721,0.0005880989,0.002389399,0.000165511,0.00007417276,0.002014769],"genre_scores_gemma":[0.0001299445,0.9898813,0.0001278851,0.0006902874,0.004169831,0.0006996028,0.0002362788,0.0001215514,0.003943356],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9744551,"threshold_uncertainty_score":0.9995883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0268176866030579,"score_gpt":0.3380587351365086,"score_spread":0.3112410485334507,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}